{"id":"clopirin-2","safety":{"commonSideEffects":[{"rate":null,"effect":"Bleeding"},{"rate":null,"effect":"Dyspepsia"},{"rate":null,"effect":"Rash"}]},"_chembl":{"chemblId":"CHEMBL499175","moleculeType":"Protein","molecularWeight":"828.02"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Clopirin 2 is a clopidogrel-based antiplatelet medication that works by irreversibly inhibiting platelet P2Y12 adenosine diphosphate receptors, preventing platelet activation and aggregation. This mechanism reduces the formation of blood clots and is used to prevent cardiovascular and cerebrovascular thrombotic events in patients at risk.","oneSentence":"Clopirin 2 is an antiplatelet agent that inhibits platelet aggregation to reduce thrombotic events.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:30:19.842Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of atherothrombotic events in patients with acute coronary syndrome"},{"name":"Secondary prevention of myocardial infarction and stroke"}]},"trialDetails":[{"nctId":"NCT02410083","phase":"PHASE4","title":"Trial to Assess the Efficacy of Combination Formula of Aspirin Plus Clopidogrel in Patients With Coronary Stent","status":"COMPLETED","sponsor":"Jeil Pharmaceutical Co., Ltd.","startDate":"2012-11","conditions":"ANEURYSM CORONARY ARTERY","enrollment":448}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":9977254,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Clopirin 2","genericName":"Clopirin 2","companyName":"Jeil Pharmaceutical Co., Ltd.","companyId":"jeil-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Clopirin 2 is an antiplatelet agent that inhibits platelet aggregation to reduce thrombotic events. Used for Prevention of atherothrombotic events in patients with acute coronary syndrome, Secondary prevention of myocardial infarction and stroke.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}